Merck Spending $275 Million on Swiss Biotech Centre

GALWAY, IRELAND--February 10, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--German drugmaker Merck KGaA is planning to spend 250 million euro ($275 million) to build a new facility for biotech development and manufacturing for clinical studies at its Corsier-sur-Vevey site in Switzerland.

Within this article: Details investment in Swiss plant, planned usage, additional Swiss and German investments